US Patent 7247300 Therapeutic use of soluble CD39L3
Patent 7247300 was granted and assigned to APT Therapeutics on July, 2007 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7247300 Therapeutic use of soluble CD39L3
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.